Parenteral Nutrition Market Set to Double, Reaching USD 13.53 Billion by 2035

The global parenteral nutrition market is forecast to be worth USD 6,370 million in 2025, as per Fact.MR estimates that the industry will witness a growth rate of 7.8% during the forecast period 2025 to 2035 and will be valued at USD 13,530 million by the end of the forecast period. It is spurred mainly by the increasing number of chronic diseases and gastrointestinal complications that impair healthy nutrient absorption, thus requiring intravenous nutritional care.

An elderly population, more hospitalizations, and an escalation of preterm deliveries worldwide are further fueling demand in the parenteral nutrition market, particularly in developed healthcare setups. Parenteral nutrition (PN) is a critical part of clinical nutrition for patients who cannot take or absorb sufficient nutrients through the gastrointestinal tract.

It is utilized across neonatal intensive care units (NICUs), adult critical care, oncology, and postoperative recovery, where enteral nutrition is contraindicated or ineffective. The move towards tailored nutrition programs is driving the formation of customized PN formulations, addressing patient needs and clinical circumstances, thereby enhancing patient outcomes and reducing complications.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=7092

Market Drivers

Rising Prevalence of Chronic Diseases
The growing incidence of cancer, Crohn's disease, short bowel syndrome, and other gastrointestinal conditions has escalated the need for parenteral nutrition. Cancer patients undergoing chemotherapy or radiotherapy often suffer from malnutrition, requiring intravenous nutrient support. Similarly, patients with severe digestive disorders that impair nutrient absorption are key recipients of PN.

Growth in Preterm Births
Preterm birth complications are among the leading causes of neonatal mortality. Parenteral nutrition is essential in managing neonates with underdeveloped digestive systems. The increase in preterm deliveries, especially in low- and middle-income countries, fuels demand for neonatal parenteral nutrition solutions.

Increasing Geriatric Population
Elderly individuals are more susceptible to chronic illnesses, postoperative complications, and malnutrition. With the global population aging rapidly, particularly in Europe, Japan, and North America, the demand for PN in long-term care and hospital settings is anticipated to rise.

Technological Advancements in Formulations
Pharmaceutical innovations have led to more stable, safer, and customizable PN solutions, which enhance patient outcomes and reduce complications like infections or liver damage. Multichamber bags, for instance, offer ease of administration and better compliance.

Market Segmentation

By Nutrient Type:

Carbohydrates: Commonly provided in the form of dextrose, essential for energy supply.
Amino Acids: Crucial for protein synthesis and tissue repair.
Lipids: Important for energy and essential fatty acids.
Electrolytes, Vitamins, and Minerals: For maintaining physiological balance.
Among these, amino acids and carbohydrates dominate the market due to their central role in patient recovery and metabolism.

By End-User:

Hospitals
Clinics
Home Care Settings
Hospitals are the largest revenue-generating segment, as PN is primarily administered in critical care and surgical recovery units. However, home parenteral nutrition (HPN) is gaining traction with advances in infusion devices and growing outpatient care.

Regional Insights

North America

North America leads the parenteral nutrition market due to a robust healthcare infrastructure, high healthcare spending, and a large base of patients with chronic diseases and cancer. The U.S. accounts for a major share, supported by government initiatives and insurance coverage for PN.

Europe

Europe follows closely, with a strong focus on clinical nutrition and well-developed neonatal and geriatric care systems. Countries like Germany, the U.K., and France are key contributors.

Asia-Pacific

Asia-Pacific is projected to witness the fastest growth during the forecast period, driven by a high birth rate, growing medical tourism, increasing chronic disease burden, and improving healthcare access in countries like China, India, and Southeast Asia.

Latin America and Middle East & Africa (MEA)

These regions are showing gradual improvements due to expanding healthcare investments, although challenges such as affordability and lack of infrastructure remain barriers.

Key Players and Competitive Landscape

The global parenteral nutrition market is moderately consolidated, with several multinational companies dominating the landscape. Key players include:

Baxter International Inc.
Fresenius Kabi AG
B. Braun Melsungen AG
Pfizer Inc.
Grifols S.A.
Amsino International, Inc.
Otsuka Pharmaceutical Factory, Inc.
Servona GmbH
These companies are engaged in R&D, strategic collaborations, and acquisitions to expand their product portfolio and geographic reach. Baxter and Fresenius Kabi, for instance, have maintained leadership through continuous innovation and global distribution networks.

Future Opportunities

Home Parenteral Nutrition (HPN)
The rising trend of outpatient and home-based care offers substantial opportunities. With telemedicine integration and user-friendly infusion devices, patients requiring long-term PN can now manage therapy at home under supervision, improving quality of life and reducing hospitalization costs.

Personalized Nutrition Solutions
Advances in personalized medicine are influencing clinical nutrition. Tailored PN formulations based on individual metabolic profiles and disease states are emerging as a key trend.

Expansion in Emerging Markets
Governments in emerging economies are ramping up healthcare infrastructure and insurance coverage. This, coupled with awareness programs, can unlock massive demand in these high-population regions.

Integration of AI and Digital Health
Artificial intelligence and smart infusion pumps are transforming how PN is administered and monitored. AI-driven dose optimization and real-time monitoring reduce risks and improve outcomes.

Challenges

Despite its growth, the parenteral nutrition market faces notable challenges:

Risk of Infections and Complications: Catheter-related bloodstream infections (CRBSIs), liver complications, and metabolic issues can arise with PN.
High Costs: PN therapy is expensive due to specialized equipment and nutrients, limiting access in resource-poor settings.
Regulatory Hurdles: Strict regulations around formulation, sterility, and drug safety can delay product approvals

Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=7092

Conclusion

The parenteral nutrition market is on a dynamic growth path, driven by demographic trends, rising disease burden, and advancements in healthcare delivery. While developed regions dominate current market share, the next growth wave is expected to come from Asia-Pacific and Latin America.

Manufacturers that invest in innovative formulations, patient-centric care models, and expand into emerging markets will be best positioned to thrive. Simultaneously, addressing safety, affordability, and regulatory compliance remains essential to long-term success in this critical healthcare domain.

Explore More Related Studies Published by Fact.MR Research:

Healthcare Contract Research Outsourcing Market

https://www.factmr.com/report/healthcare-contract-research-outsourcing-market

Collagen and HA-based Biomaterials Market

https://www.factmr.com/report/collagen-and-ha-based-biomaterials-market

Wireless Health and Fitness Devices Market

https://www.factmr.com/report/wireless-health-and-fitness-devices-market

Energy-based Aesthetic Devices Market

https://www.factmr.com/report/energy-based-aesthetic-devices-market

Wound Care Biologics Market

https://www.factmr.com/report/wound-care-biologics-market

Trauma Care Centers Market

https://www.factmr.com/report/trauma-care-centers-market

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.